David Biernbaum
From Wikipedia, the free encyclopedia
| This article does not cite any references or sources. (December 2007) Please help improve this article by adding citations to reliable sources. Unverifiable material may be challenged and removed. |
| This article or section needs to be wikified to meet Wikipedia's quality standards. Please help improve this article with relevant internal links. (November 2007) |
| This article may not meet the general notability guideline or one of the following specific guidelines for inclusion on Wikipedia: Biographies, Books, Companies, Fiction, Music, Neologisms, Numbers, Web content, or several proposals for new guidelines. If you are familiar with the subject matter, please expand or rewrite the article to establish its notability. The best way to address this concern is to reference published, third-party sources about the subject. If notability cannot be established, the article is more likely to be considered for redirection, merge or ultimately deletion, per Wikipedia:Guide to deletion. This article has been tagged since October 2007. |
David Biernbaum is a St. Louis, Missouri based, nationally known consumer packaged goods specialist, columnist, instructor, and published author, in the field of marketing, retail sales, and business development, with a far-reaching background and resilient history developing major national brands, niche items, licensed goods, and premium store brands.
Biernbaum has nearly 30 years of expertise developing national and niche consumer goods and brands distributed in retail chains such as Wal-Mart, Target, Walgreens, CVS, grocery chains, etc.
David Biernbaums leadership was instrumental to help develop St. Louis based Vi-Jon Laboratories to become a major force in private label personal care products, and Wichita Falls, Texas based Zooth Inc., during its most propelling growth years before the company was acquired by Gillette, and later sold to Procter and Gamble. Biernbaum helped develop Michigan based OraWave LLC, and its formable partnership with the Susan G. Komen Breast Cancer Research organization, and currently he is developing TheraBreath brands with Dr. Harold Katz, an internationally known expert on the topic of fresh breath.
Biernbaum has also developed other companies and brands such as Chicago based, Fresh & Go USA, and St. Louis based, Ultradata Systems, Inc. where he was Chief Operating Officer. In the late 1970's, Biernbaum assisted the national U.S.A test launch of Aquafresh oral care brands for U.K. based Smith Kline Beecham, and later, in the 1980's, he managed the Central U.S. for the Oral-B Laboratories branded products for Boston MA based, Gillette Co.
David Biernbaum is a frequent columnist, panelist, and contributor for consumer goods trade shows, instructional workshops, and panels, and has written several columns for trade magazines such as MMR, Chain Drug Review, ECRM Focus, and Private Label Buyer. Biernbaum has held active leadership roles in trade organizations such as The National Association of Chain Drug Stores (NACDS) and Efficient Consumer Response Management (ECRM.)
Today, David Biernbaum is president and senior consultant at David Biernbaum Associates, a St. Louis, MO based national consulting firm to the mass markets and consumer goods industry. http://www.biernbaum.com. He also is Sr. Marketing/Sales VP at Los Angeles CA based, Dr. Harold Katz LLC.
David Biernbaum is a member of the RETAILWIRE "BrainTrust Panel," and a daily contributor: http://www.retailwire.com.
| This article or section needs sources or references that appear in reliable, third-party publications. Primary sources and sources affiliated with the subject of the article are generally not sufficient for a Wikipedia article. Please include more appropriate citations from reliable sources, or discuss the issue on the talk page. This article has been tagged since November 2007. |
| This article lacks information on the notability of the subject matter. Please help improve this article by providing context for a general audience, especially in the lead section. (November 2007) |

